Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.

Li, Ying Fei; Combes, Francois Pierre; Hoch, Matthias; Lorenzo, Sebastien; Sy, Sherwin K B; Ho, Yu-Yun

Li, Ying Fei; Combes, Francois Pierre; Hoch, Matthias; Lorenzo, Sebastien; Sy, Sherwin K B; Ho, Yu-Yun.

Affiliation

Li YF; Novartis Pharmaceutical Corporation, East Hanover, New Jersey, USA. ying_fei.li@novartis.com.
Combes FP; Novartis Pharmaceutical Corporation, East Hanover, New Jersey, USA.
Hoch M; Novartis Institute for Biomedical Research, Basel, Switzerland.
Lorenzo S; Novartis Pharmaceutical Corporation, Basel, Switzerland.
Sy SKB; Novartis Pharmaceutical Corporation, East Hanover, New Jersey, USA.
Ho YY; Novartis Pharmaceutical Corporation, East Hanover, New Jersey, USA.

Clin Pharmacokinet ; 61(10): 1393-1403, 2022 Oct.

Article in En | MEDLINE | ID: mdl-35764773

Subject(s)

Antineoplastic Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Fusion Proteins, bcr-abl/genetics; Fusion Proteins, bcr-abl/therapeutic use; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics; Niacinamide/analogs & derivatives; Philadelphia Chromosome; Protein Kinase Inhibitors/therapeutic use; Pyrazoles

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacokinet Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google